Meropenem and Moviprep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meropenem (meropenem) and Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate). Common drug interactions include ageusia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Meropenem and Moviprep. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.



On Jul, 20, 2026

15 people who take Meropenem and Moviprep together, and have interactions are studied.

Meropenem and Moviprep drug interactions.

What are the common drug interactions of Meropenem and Moviprep, by gender? *:

female:

  1. Ageusia (loss of taste functions of the tongue)
  2. Angular cheilitis (inflammation of one, or more commonly both, of the corners of the mouth)
  3. Back pain
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Decreased appetite
  6. Dehydration (dryness resulting from the removal of water)
  7. Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
  8. Myalgia (muscle pain)
  9. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  10. Upper respiratory tract inflammation

male:

  1. Asthenia (weakness)
  2. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  3. Post procedural complication
  4. Pyrexia (fever)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Small intestine ulcer
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  10. Colitis ulcerative (inflammation of colon with ulcer)

What are the common drug interactions of Meropenem and Moviprep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Angular cheilitis (inflammation of one, or more commonly both, of the corners of the mouth)
  2. Back pain
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Dehydration (dryness resulting from the removal of water)
  5. Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
  6. Myalgia (muscle pain)
  7. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  8. Upper respiratory tract inflammation
  9. Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
  10. Adenovirus infection

10-19:

  1. Ageusia (loss of taste functions of the tongue)
  2. Decreased appetite

20-29:

  1. Pyrexia (fever)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Asthenia (weakness)
  5. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  6. Colitis ulcerative (inflammation of colon with ulcer)
  7. Delirium (wild excitement)
  8. General physical health deterioration (weak health status)
  9. Pain
  10. Pneumonia

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  2. Small intestine ulcer

What are the existing conditions these people have? *

  1. Pneumonia: 5 people, 33.33%
  2. Upper Respiratory Tract Inflammation: 3 people, 20.00%
  3. Angular Cheilitis (inflammation of one, or more commonly both, of the corners of the mouth): 3 people, 20.00%
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 20.00%
  5. Pharyngitis (inflammation of the pharynx, causing a sore throat): 3 people, 20.00%
  6. Pain: 3 people, 20.00%
  7. Cystic Fibrosis (disease of the secretary glands): 3 people, 20.00%
  8. Cystic Fibrosis Pancreatic (fibrosis with cyst in the pancreas): 3 people, 20.00%
  9. Nausea (feeling of having an urge to vomit): 3 people, 20.00%
  10. Muscle Aches (muscle pain): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and Moviprep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Meropenem and Moviprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Moviprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meropenem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Moviprep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meropenem and ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Meropenem and Moviprep, respectively), and Meropenem and Moviprep (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: